Physician profile
Shannon Renee Winstead
NPI 1225477797
$1,685.29
in general payments reported to CMS, 2019-2025
11 companies · $398 in 2025
The $398 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.90 · 2020: $128 · 2021: $45.28 · 2022: $267 · 2023: $375 · 2024: $406 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,177.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $428.55 | 2019-2025 | Precision7, Total30, Precision 1 |
| Bausch & Lomb Americas INC. | $350.30 | 2022-2025 | Infuse, Miebo |
| Coopervision INC. | $339.54 | 2020-2025 | Misight Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Topcon Healthcare, INC. | $187.75 | 2023-2024 | |
| Allergan, INC. | $114.22 | 2021-2022 | |
| Lkc Technologies, INC. | $108.54 | 2022-2023 | |
| Optovue, INC. | $55.47 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $53.50 | 2020-2021 | |
| Abbvie INC. | $17.49 | 2022 | |
| Carl Zeiss Meditec Ag | $17.20 | 2020 | |
| Novartis Pharmaceuticals Corporation | $12.73 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Winstead listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.